J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ — J INTS BIO announced research findings on its innovative brain tumor treatment, ‘JIN-001,’ developed... Read more.
TTA and O-RAN ALLIANCE Signed Agreement to Cooperate on Standardization of Open RAN Technology
WASHINGTON and BONN, Germany, Nov. 25, 2024 /PRNewswire/ — TTA and O-RAN ALLIANCE have officially announced the signing of a Cooperation Agreement (CA) that... Read more.
Global Elite Training of World Internet Conference Digital Academy Begins
WUZHEN, China, Nov. 24, 2024 /PRNewswire/ — A news report from CRIOnline: On November 21, the launch ceremony for the Global Elite Training of the World... Read more.
ONEOK Announces Agreement to Acquire Remaining Publicly Held Common Units in EnLink Midstream in a Tax-Free Transaction
Consideration of 0.1412 shares of ONEOK common stock for each outstanding publicly held EnLink common unit TULSA, Okla., Nov. 24, 2024 /PRNewswire/ — ONEOK,... Read more.
Forging Ahead Together for Greater Heights｜WEPACK ASEAN 2024 Concludes Successfully
SHANGHAI, Nov. 24, 2024 /PRNewswire/ — As 2024 draws to a close, we ushered in Malaysia’s grand packaging industry event – WEPACK ASEAN 2024, which... Read more.
Kuaishou Technology to Become Constituent of Hong Kong’s Hang Seng Index
HONG KONG, Nov. 24, 2024 /PRNewswire/ — Kuaishou Technology (“Kuaishou” or the “Company”; HKD Counter Stock Code: 01024 / RMB Counter... Read more.
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing... Read more.
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024
SAN FRANCISCO and SUZHOU, China, Nov. 24, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies... Read more.
Minister Khera highlights the government’s tax break for all Canadians and new Working Canadians Benefits
CALEDON, ON, Nov. 24, 2024 /CNW/ – The past few years have been challenging. It feels like the price of everything has gone up. And while inflation is back... Read more.